Osmetech plc Newsroom - Profile and News Archive

Osmetech plc | Osmetech plc, Minerva Biotechnologies Corporation, James White, Harvard SAM IP, self-assembling monolayer technology, nanoparticle technology, near patient testing market, functionalized attachment of molecules to surfaces and reduce nonspecific aggregation events, LSE AIM OMH

Engage with Osmetech plc

Follow: 

RSS News Feed for Osmetech plc

Press Releases from Osmetech plc :

Osmetech Licenses Self-Assembling Monolayer (SAM) Technology to Minerva Biotechnologies Corporation


PASADENA, Calif. – June 18 (SEND2PRESS NEWSWIRE) — Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation (‘Minerva’) for use of Osmetech’s self-assembling monolayer (SAM) technology in conjunction with Minerva’s proprietary nanoparticle technology.

Osmetech Licenses Roche Hot Start(R) Polymerase Technology


PASADENA, Calif. – June 5 (SEND2PRESS NEWSWIRE) — Osmetech plc (AIM; LSE: OMH) today announced that it has been granted a non-exclusive worldwide diagnostics license from Swiss-based F. Hoffman LaRoche Ltd and its US affiliate Roche Molecular Systems Inc. (collectively ‘Roche’) to use Hot Start(R) polymerase technology in Osmetech nucleic acid diagnostic assays.